KalVista Pharmaceuticals (KALV) Shares Issued (2018 - 2024)
Historic Shares Issued for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q4 2024 value amounting to $295000.0.
- KalVista Pharmaceuticals' Shares Issued rose 13046.88% to $295000.0 in Q4 2024 from the same period last year, while for Apr 2025 it was $99.6 million, marking a year-over-year increase of 301.63%. This contributed to the annual value of $55.9 million for FY2025, which is 4232.71% down from last year.
- KalVista Pharmaceuticals' Shares Issued amounted to $295000.0 in Q4 2024, which was up 13046.88% from $3.0 million recorded in Q3 2024.
- Over the past 5 years, KalVista Pharmaceuticals' Shares Issued peaked at $96.3 million during Q2 2024, and registered a low of $46000.0 during Q3 2020.
- Its 3-year average for Shares Issued is $16.7 million, with a median of $249500.0 in 2023.
- Its Shares Issued has fluctuated over the past 5 years, first tumbled by 9959.73% in 2020, then surged by 137058.82% in 2024.
- KalVista Pharmaceuticals' Shares Issued (Quarter) stood at $46000.0 in 2020, then skyrocketed by 178.26% to $128000.0 in 2023, then skyrocketed by 130.47% to $295000.0 in 2024.
- Its Shares Issued stands at $295000.0 for Q4 2024, versus $3.0 million for Q3 2024 and $96.3 million for Q2 2024.